Surgeon with mask on looking at a brain x-ray with Vega star on top of image

Breaking Neurosurgical Barriers

most common condition requiring neurosurgical intervention.

150,000+ Hospitalizations

Driven by our aging population, by 2030 CSDH is projected to be the

Driven by our aging population, by 2030 CSDH is projected to be the most common condition requiring neurosurgical intervention.

A stylized red and black butterfly logo with aggressive teeth in the middle.
Illustration of Vega's Cranial Drill
Illustration of Vega's Port Device

Proprietary Technology

XCAPE™ Cranial Port

Engineered for optimal intracranial access and controlled fluid evacuation, delivering seamless integration, superior visualization, and flexible use across clinical settings.

Learn more

XPD™ Access System

Designed for precision and safety, this high-performance system streamlines cranial access for multiple procedures.

Learn more

Advancing Neurosurgical Care for Everyone

Patients

Delivers safer, faster and better outcomes.

Hospitals

Versatility and efficiency streamlines care, reducing resource utilization and cost.

Providers

Empowers timely, effective care while optimizing reimbursement and workflow efficiency.

Surgeon designed, surgeon tested

Vega's XCAPE™ cranial system is designed by surgeons for surgeons. XCAPE™'s proprietary technology delivers effective and efficient treatment to maximize patient outcomes and surgeon productivity.

Surgeon with mask on and tools in his gloved hands
A close-up of a 3D printer nozzle extruding white filament onto a build plate.

Advanced engineering, continuous innovation

The team has spent the past five years refining the XCAPE™ and XPD™ systems through cadaver, animal, and benchtop testing. With continuous innovation and rigorous validation, we’ve created high-performing devices that deliver greater safety, control, and ease of use in neurosurgical procedures.

Our Team

Vega Surgical is a Colorado company founded by two neurosurgeons from the University of Colorado, who have firsthand knowledge of the challenges in treating patients with CSDHs, and a biomedical engineer with experience bringing medical devices to market.

  • Headshot of Dr Joshua Seinfeld

    Joshua Seinfeld MD

    Co-Founder & CEO

    Dr. Seinfeld is the CEO of VEGA Surgical, Professor of Neurosurgery, and the Director of Endovascular Neurosurgery at CU. Having graduated from the CU Neurosurgery Residency program in 2008 and the Massachusetts General Hospital Interventional Neuroradiology fellowship in 2009, he has been in practice for over 15 years. Dr. Seinfeld has served as an investigator in numerous trials in the field of neurosurgery. Beyond the operating room, Dr. Seinfeld has been a consultant/advisor to several medical device companies.

  • Headshot of Dr Zach Folzenlogen

    Zach Folzenlogen MD

    Co-Founder & CMO

    Dr. Folzenlogen is the CMO of VEGA Surgical and the Director of Neurovascular Service at Highlands Ranch Hospital. He has specialized in brain and spinal cord neurovascular conditions for over ten years since graduating from Florida State University College of Medicine. Dr. Folzenlogen is developing minimally invasive neurosurgical techniques to improve patient outcomes and facilitate efficient care.

  • Headshot of Michael Bojanowski

    Michael Bojanowski

    Co-Founder & CTO

    Mr. Bojanowski is the Chief Technology Officer of VEGA Surgical. Over the past 21 years, he has held several executive management, research and development, engineering, and manufacturing roles. He is a founding member of four bioscience companies and is an active mentor to early-stage startups. Having brought surgical implants, drug delivery systems, electrosurgery, surgical robotics, and connected at-home devices to market, he is well-positioned to lead the VEGA Surgical product development team.